Literature DB >> 29850114

Risk factors for primary Sjögren syndrome-associated interstitial lung disease.

Yong Wang1,2, Ziliang Hou1, Meihua Qiu1, Qiao Ye1.   

Abstract

BACKGROUND: Primary Sjögren syndrome (pSS) is a chronic inflammatory autoimmune disease that is characterized by lymphocytic infiltration of the exocrine glands and extraglandular organ systems. Interstitial lung disease (ILD) is common in pSS patients and is one of the independent risk factors for a poor prognosis. The previously reported characteristics and potential risks contributing to pSS-associated ILD have been controversial.
METHODS: A cohort of 201 newly diagnosed pSS patients were studied over a period of 3 years. Data were from clinical charts. The pSS patients were classified into two groups, namely pSS-ILD or pSS without ILD, according to the lung evaluation.
RESULTS: In total, the prevalence of pSS-associated ILD was 78.6%. The pSS patients associated ILD were more likely to be male, older and smokers in comparison to the pSS patients without ILD. There were no significant differences in multiorgan involvement between the two groups. Nonspecific interstitial pneumonia (NSIP) was the most common radiological pattern (45.5%). pSS with ILD was associated with increasing age [odds ratio (OR) =1.073], smoking (OR =8.544) and antinuclear antibody (ANA) positive (OR =3.286). Over a median follow-up period of 24 months (range, 18-30 months), no patients died, experienced acute exacerbation of ILD, or had newly diagnosed pSS-ILD.
CONCLUSIONS: pSS associated ILD were more commonly in males, older patients and smokers. Aging, cigarette smoking, and ANA positivity may be potential risk factors contributing to ILD in pSS patients.

Entities:  

Keywords:  Primary Sjögren syndrome (pSS); antinuclear antibody (ANA); interstitial lung disease (ILD); risk factors; smoking

Year:  2018        PMID: 29850114      PMCID: PMC5949459          DOI: 10.21037/jtd.2018.03.120

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  37 in total

Review 1.  Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature.

Authors:  Vrishali Dalvi; Emilio B Gonzalez; Louis Lovett
Journal:  Clin Rheumatol       Date:  2006-08-05       Impact factor: 2.980

2.  Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan.

Authors:  Hiroto Tsuboi; Hiromitsu Asashima; Chinatsu Takai; Shinya Hagiwara; Chihiro Hagiya; Masahiro Yokosawa; Tomoya Hirota; Hisanori Umehara; Atsushi Kawakami; Hideki Nakamura; Hajime Sano; Kazuo Tsubota; Yoko Ogawa; Etsuko Takamura; Ichiro Saito; Hiroko Inoue; Seiji Nakamura; Masafumi Moriyama; Tsutomu Takeuchi; Yoshiya Tanaka; Shintaro Hirata; Tsuneyo Mimori; Hajime Yoshifuji; Akiko Ohta; Isao Matsumoto; Takayuki Sumida
Journal:  Mod Rheumatol       Date:  2013-11-05       Impact factor: 3.023

3.  Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.

Authors:  Xiaomei Li; Bei Xu; Yan Ma; Xiangpei Li; Qi Cheng; Ximei Wang; Guosheng Wang; Long Qian; Li Wei
Journal:  Int J Rheum Dis       Date:  2015-04-30       Impact factor: 2.454

Review 4.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

5.  Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

Authors:  Pilar Brito-Zerón; Nihan Acar-Denizli; Margit Zeher; Astrid Rasmussen; Raphaele Seror; Elke Theander; Xiaomei Li; Chiara Baldini; Jacques-Eric Gottenberg; Debashish Danda; Luca Quartuccio; Roberta Priori; Gabriela Hernandez-Molina; Aike A Kruize; Valeria Valim; Marika Kvarnstrom; Damien Sene; Roberto Gerli; Sonja Praprotnik; David Isenberg; Roser Solans; Maureen Rischmueller; Seung-Ki Kwok; Gunnel Nordmark; Yasunori Suzuki; Roberto Giacomelli; Valerie Devauchelle-Pensec; Michele Bombardieri; Benedikt Hofauer; Hendrika Bootsma; Johan G Brun; Guadalupe Fraile; Steven E Carsons; Tamer A Gheita; Jacques Morel; Cristina Vollenveider; Fabiola Atzeni; Soledad Retamozo; Ildiko Fanny Horvath; Kathy Sivils; Thomas Mandl; Pulukool Sandhya; Salvatore De Vita; Jorge Sanchez-Guerrero; Eefje van der Heijden; Virginia Fernandes Moça Trevisani; Marie Wahren-Herlenius; Xavier Mariette; Manuel Ramos-Casals
Journal:  Ann Rheum Dis       Date:  2016-11-29       Impact factor: 19.103

6.  Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

Authors:  B K Davidson; C A Kelly; I D Griffiths
Journal:  Rheumatology (Oxford)       Date:  1999-03       Impact factor: 7.580

7.  A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.

Authors:  Yongzhe Li; Kunlin Zhang; Hua Chen; Fei Sun; Juanjuan Xu; Ziyan Wu; Ping Li; Liuyan Zhang; Yang Du; Haixia Luan; Xi Li; Lijun Wu; Hongbin Li; Huaxiang Wu; Xiangpei Li; Xiaomei Li; Xiao Zhang; Lu Gong; Lie Dai; Lingyun Sun; Xiaoxia Zuo; Jianhua Xu; Huiping Gong; Zhijun Li; Shengquan Tong; Min Wu; Xiaofeng Li; Weiguo Xiao; Guochun Wang; Ping Zhu; Min Shen; Shengyun Liu; Dongbao Zhao; Wei Liu; Yi Wang; Cibo Huang; Quan Jiang; Guijian Liu; Bin Liu; Shaoxian Hu; Wen Zhang; Zhuoli Zhang; Xin You; Mengtao Li; Weixin Hao; Cheng Zhao; Xiaomei Leng; Liqi Bi; Yongfu Wang; Fengxiao Zhang; Qun Shi; Wencheng Qi; Xuewu Zhang; Yuan Jia; Jinmei Su; Qin Li; Yong Hou; Qingjun Wu; Dong Xu; Wenjie Zheng; Miaojia Zhang; Qian Wang; Yunyun Fei; Xuan Zhang; Jing Li; Ying Jiang; Xinping Tian; Lidan Zhao; Li Wang; Bin Zhou; Yang Li; Yan Zhao; Xiaofeng Zeng; Jurg Ott; Jing Wang; Fengchun Zhang
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

8.  Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.

Authors:  D Deheinzelin; V L Capelozzi; R A Kairalla; J V Barbas Filho; P H Saldiva; C R de Carvalho
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype.

Authors:  Claire M Robinson; Roisin Neary; Ashleigh Levendale; Chris J Watson; John A Baugh
Journal:  Respir Res       Date:  2012-08-31
View more
  10 in total

1.  TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndrome.

Authors:  Margherita Sisto; Loredana Lorusso; Giuseppe Ingravallo; Domenico Ribatti; Sabrina Lisi
Journal:  Lab Invest       Date:  2020-01-10       Impact factor: 5.662

2.  Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.

Authors:  Shuqiao Yang; Dandan Chai; Yihua Li; Yuanying Wang; Xi Zhan; Liming Zhang; Jing Wang; Qiao Ye
Journal:  Clin Rheumatol       Date:  2021-11-27       Impact factor: 2.980

3.  Prognostic Predictive Characteristics in Patients With Fibrosing Interstitial Lung Disease: A Retrospective Cohort Study.

Authors:  Yuanying Wang; Ziyun Guo; Ruimin Ma; Jingwei Wang; Na Wu; Yali Fan; Qiao Ye
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

4.  Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.

Authors:  Lei Shi; Jia Wang; Hong-Xia Guo; Xiao-Lei Han; Yu-Ping Tang; Guang-Ying Liu
Journal:  Arthritis Res Ther       Date:  2022-05-23       Impact factor: 5.606

5.  Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.

Authors:  Yuying Zhang; Mengtao Li; Liyun Zhang; Qin Li; Pinting Yang; Xiaodan Kong; Xinwang Duan; Miaojia Zhang; Xiaomei Li; Yongfu Wang; Jian Xu; Yanhong Wang; Evelyn Hsieh; Jiuliang Zhao; Dong Xu; Yan Zhao; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2020-03-07       Impact factor: 2.980

6.  Quantitative assessment of interstitial lung disease in Sjögren's syndrome.

Authors:  Pablo Guisado-Vasco; Mario Silva; Miguel Angel Duarte-Millán; Gianluca Sambataro; Chiara Bertolazzi; Mauro Pavone; Isabel Martín-Garrido; Oriol Martín-Segarra; José Manuel Luque-Pinilla; Daniele Santilli; Domenico Sambataro; Sebastiano E Torrisi; Ada Vancheri; Marwin Gutiérrez; Mayra Mejia; Stefano Palmucci; Flavio Mozzani; Jorge Rojas-Serrano; Carlo Vanchieri; Nicola Sverzellati; Alarico Ariani
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

7.  Autoantibodies in Sjögren's syndrome and its classification criteria.

Authors:  Sharon Veenbergen; Ana Kozmar; Paul L A van Daele; Marco W J Schreurs
Journal:  J Transl Autoimmun       Date:  2021-12-27

8.  Interstitial lung disease in Primary Sjögren's syndrome.

Authors:  Wei Lin; Zhifei Xin; Jianlong Zhang; Ning Liu; Xiuying Ren; Meilu Liu; Yashuang Su; Yixuan Liu; Liu Yang; Shaoying Guo; Yupeng Yang; Yang Li; Jingjing Cao; Xiaoran Ning; Jingjing Li; He Xue; Nannan Niu; Yingmin Chen; Fang Li; Lijun Sun; Xiaopeng Zhang; Fengxiao Zhang; Wen Zhang
Journal:  BMC Pulm Med       Date:  2022-02-27       Impact factor: 3.317

9.  Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.

Authors:  Lin Weng; Yaqiong Chen; Tao Liang; Yihua Lin; Dehao Liu; Ciyong Yu; Yudi Hu; Wei Lui; Yongliang Liu; Xiangfang Chen; Qiyuan Li; Shengxiang Ge; Dana P Ascherman; Juan Chen
Journal:  Eur J Med Res       Date:  2022-10-10       Impact factor: 4.981

10.  Ten-year survival analysis of patients with primary Sjögren's syndrome in China: a national prospective cohort study.

Authors:  Junyan Qian; Chengmei He; Ya Li; Linyi Peng; Yunjiao Yang; Dong Xu; Yunyun Fei; Wen Zhang; Yan Zhao; Yi Dong; Yongzhe Li; Xuan Zhang; Hua Chen; Yanlei Yang; Zhilei Chen; Suying Liu; Li Wang; Fengchun Zhang
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-23       Impact factor: 5.346

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.